RNA vaccines Part 2: Addressing ongoing challenges

VACCINE INSIGHTS

October 2023

RNA vaccines Part 2: Addressing ongoing challenges

Download PDF

Innovator Insight

Achieving vaccine equity: challenges & opportunities of multi-modality manufacturing

Achieving vaccine equity: challenges & opportunities of multi-modality manufacturing

Katarina Stenklo

20 December 2023

Regulatory perspective

Nonclinical development of RNA cancer vaccines: proof-of-concept testing, safety study design, and future prospects

Nonclinical development of RNA cancer vaccines: proof-of-concept testing, safety study design, and future prospects

Rondine Allen, Christopher Saeui

9 November 2023

Interview

Optimizing in vitro transcription reactions: from fundamental research to mRNA vaccine manufacturing

Optimizing in vitro transcription reactions: from fundamental research to mRNA vaccine manufacturing

8 November 2023

Developing an effective vaccine formulation using self-amplifying RNA and a nanoparticle emulsion

Developing an effective vaccine formulation using self-amplifying RNA and a nanoparticle emulsion

8 November 2023

Webinars

Better mRNA-LNPs: encapsulation efficiency, mRNA integrity and purity, lipid N-oxides, and beyond

Better mRNA-LNPs: encapsulation efficiency, mRNA integrity and purity, lipid N-oxides, and beyond

Beyond mRNA - how advances in analytical techniques are enabling a revolution of the RNA drug landscape

Beyond mRNA - how advances in analytical techniques are enabling a revolution of the RNA drug landscape

Andrew Geall

13 September 2023

Fine-tuning your mRNA-LNP formulation with an innovative cationic lipid library

Fine-tuning your mRNA-LNP formulation with an innovative cationic lipid library

Nathan Chaboche, Quentin Huaulmé

25 October 2023